Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL6512029 | 0.98 | TSHR (0.34) | TSHRALPLPOLBALPGALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL9569011 | 0.83 | CYP3A4 (0.32) | TSHRALPLPOLBALPGCYP3A4 | |
| SCHEMBL9417419 | 0.78 | CYP3A4 (0.37) | TSHRALPLPOLBALPGCYP3A4 | |
| Ammonia Solution, Strong SCHEMBL8930985 | 0.76 | ALPL (0.30) | ALPLPOLBALPG | |
| Ammonia Solution, Strong SCHEMBL11151837 | 0.72 | ACHE (0.32) | TSHR | |
| Ammonia Solution, Strong SCHEMBL897133 | 0.71 | HDAC1 (0.43) | TSHRALDH1A1LMNAAPEX1CYP3A4 | |
| SCHEMBL1427298 | 0.70 | POLB (0.50) | TSHRALPLPOLBALPGCYP3A4 | |
| Acetic Acid SCHEMBL3682296 | 0.70 | POLB (0.50) | TSHRALPLPOLBALPGCYP3A4 | |
| Ammonia Solution, Strong SCHEMBL4251676 | 0.69 | TSHR (0.34) | TSHRALDH1A1LMNAAPEX1 | |
| Ammonia Solution, Strong SCHEMBL8398387 | 0.69 | TSHR (0.34) | TSHRALDH1A1LMNAAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220000877-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. BRAUN MELSUNGEN AG (DE) | 2022-01-06 | — | — | US | disclosed |
| US-20210401848-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. BRAUN MELSUNGEN AG (DE) | 2021-12-30 | — | — | US | disclosed |
| US-9605269-B2 | Detoxification of biomass derived acetate via metabolic conversion to ethanol, acetone, isopropanol, or ethyl acetate | LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC (HU) | 2017-03-28 | — | — | US | disclosed |
| US-20130273555-A1 | Detoxification of Biomass Derived Acetate Via Metabolic Conversion to Ethanol, Acetone, Isopropanol, or Ethyl Acetate | MASCOMA CORPORATION (US) | 2013-10-17 | — | — | US | disclosed |
| WO-2011140386-A2 | DETOXIFICATION OF BIOMASS DERIVED ACETATE VIA METABOLIC CONVERSION TO ETHANOL, ACETONE, ISOPROPANOL, OR ETHYL ACETATE | MASCOMA CORPORATION (US) | 2011-11-10 | — | — | WO | disclosed |
| EP-0543689-A1 | Compositions to simultaneously tan and dye hides and their production process | UNITAN S.A.I.C.A. (AR) | 1993-05-26 | — | — | EP | disclosed |
| US-5037749-A | Cleaned animal bone with collagen matrix exposed for attachment sites | PROTEIN FOODS GROUP INC. (CA) | 1991-08-06 | — | — | US | disclosed |
| EP-0208647-A2 | Immobilisation supports for chemical and physical processes and methods of their manufacture | PROTEIN FOODS GROUP INC. (CA) | 1987-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220000877-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | MUC1, DSG1, AQP3 | TSHR 1928/4885ALPL 2005/4885POLB 375/4885 |
| US-20210401848-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | DSP, DSG1, MUC1 | TSHR 2065/4885ALPL 1970/4885POLB 816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.